Vera Therapeutics (VERA) EPS (Weighted Average and Diluted) (2021 - 2026)
Vera Therapeutics (VERA) reported EPS (Weighted Average and Diluted) of -$1.69 for Q1 2026, down 108.64% on a YoY basis from $19.56 in Q1 2025, and down 21.58% quarter-over-quarter from -$1.39 in Q4 2025.
Vera Therapeutics (VERA) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Vera Therapeutics has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at -$1.69 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 108.64% year-over-year to -$1.69; the trailing twelve-month figure through Mar 2026 stood at -$5.54 (down 84.67% YoY), and the FY2025 full-year result was -$4.66, down 69.45% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$1.69, down from -$1.39 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.45 in Q3 2023, with the low at -$1.69 in Q1 2026.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.87 across 5 years, with a median of -$0.8 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) plunged 152.78% — and 2023, when it jumped 51.26%.
- Vera Therapeutics' EPS (Weighted Average and Diluted) stood at -$1.19 in 2022, then jumped by 51.26% to -$0.58 in 2023, then slipped by 24.14% to -$0.72 in 2024, then plunged by 93.06% to -$1.39 in 2025, then slipped by 21.58% to -$1.69 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.69 (Q1 2026), -$1.39 (Q4 2025), and -$1.26 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - | -1.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69 |
| Dec 31, 2025 | -1.39 |
| Sep 30, 2025 | -1.26 |
| Jun 30, 2025 | -1.20 |
| Mar 31, 2025 | -0.81 |
| Dec 31, 2024 | -0.72 |
| Sep 30, 2024 | -0.85 |
| Jun 30, 2024 | -0.62 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -0.58 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -1.19 |
| Sep 30, 2022 | -0.91 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.71 |
| Dec 31, 2021 | -0.97 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.33 |